Critical Thinking Incident: A Patient Kidney Failure

Iosartan (Cozaar): possible angiotensin II, effective vasoconstrictor, Aldactone: potassium-conserved diuretic (water pill), Timpotic: beta blocker, coumarin prime: blood diluent tylenol saline (IV) Assume that the solution, or the human body is composed of about 60% water. However, body fluids may overload occasionally, and body fluid (mainly water) enters the body more than body fluids flow out. There are three explanations or solutions about the cause of the patient's fluid overload.

Treatment of anemia: Anemic patients are very common in patients with renal failure and tend to be more severe as the problem progresses. Normal kidney produces a hormone called erythropoietin (EPO) which stimulates the formation of erythrocytes in the bone marrow. Damaged kidneys produce less EPO and cause anemia. There is a possibility that problems will increase if iron is short. Anemia causes many symptoms of kidney failure, especially fatigue and weakness. EPO is a very effective treatment for anemia of renal failure, usually requiring weekly or biweekly injection, but initially provided by a district nurse, in many cases the patient itself or a caregiver Provided by

Chronic kidney disease (CKD) is a disease whose kidney abnormality and / or renal function declines by 3 months or more, and its effect has a negative health effect on patients with chronic renal failure. One of the most common abnormalities associated with CKD is bone and mineral abnormalities related to changes in calcium and phosphorus homeostasis. As the kidneys further decline, the disappearance of phosphorus decreases resulting in an increase in serum phosphorus levels 1. In addition, total calcium concentration decreases and serum calcium concentration decreases. Hyperphosphatemia and hypocalcemia are associated with adverse reactions to CKD patients administered to fleet enema 2

Failure is because excessive homocysteine ​​scarred and the kidney has been injured for many years? Doctors expect that homocysteine ​​concentrations in renal failure patients are high, but they have never considered the possibility that homocysteine ​​elevation is the cause, and that it is not merely a side effect. Screening for homocysteine ​​is a powerful risk factor for vascular disease in young people and the elderly and screening should be general for people at risk of cardiovascular disease. Homocysteine ​​examination should be done on a daily basis for elderly people, pregnant women, and people with the following risk factors: